- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about INMB
Recent news which mentions INMB
From Benzinga
INmune Bio, Inc. (INMB) Q4 2021 Earnings Call Transcript
March 04, 2022
Tickers
INMB
From Motley Fool
From Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 18, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 17, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 09, 2022
From Benzinga
92 Biggest Movers From Friday
November 08, 2021
From Benzinga
INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
INMB
From Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
October 25, 2021
From Benzinga
54 Biggest Movers From Yesterday
September 09, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 08, 2021
From Benzinga
30 Stocks Moving In Wednesday's Mid-Day Session
September 08, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
September 05, 2021
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 02, 2021
From Benzinga
From InvestorPlace
28 Stocks Moving in Thursday's Pre-Market Session
September 02, 2021
From Benzinga
From MarketWatch
Here's How You Handle a Volatile Stock Like Cassava Sciences
September 02, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 01, 2021
From Benzinga
Why Are Shares Of INmune Bio Trading Higher Wednesday Afternoon?
September 01, 2021
Tickers
INMB
From Benzinga
10 Stocks Moving In Wednesday's After-Hours Session
September 01, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
August 29, 2021
From Benzinga
INmune Bio Stock Jumps On Promising Biomarker Data From Early-Stage Blood Cancer Trial
August 26, 2021
Tickers
INMB
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.